Magna Investment (Seoul) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 7

Professionals

  • Investments
  • 148

  • Portfolio
  • 89

  • Exits
  • 37

Exits

Magna Investment (Seoul) General Information

Company Description

Founded in 2010, Magna Investment is a venture capital firm based in Seoul, South Korea. The firm seeks to invest in the healthcare sector.

Business Details

Website
www.mgni.co.kr
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • 14th floor, 15, Teheran-ro 98-gil
  • Gangnam-gu, Daechi-dong, Songgang Building
  • Seoul, 06181
  • South Korea
+82

Magna Investment (Seoul) Investments (148)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ensol Biosciences 12-Aug-2024 PIPE Biotechnology Generating Revenue
Altos Biologics 09-Jul-2024 Biotechnology Clinical Trials - Phase 1
CastingN 08-Jul-2024 Media and Information Services (B2B) Generating Revenue
DeepSmartech 02-Jul-2024 Industrial Supplies and Parts Generating Revenue
Nation A 18-Jun-2024 Multimedia and Design Software Generating Revenue
InterX 26-May-2024 Business/Productivity Software Generating Revenue
Siksin 25-Feb-2024 Information Services (B2C) Generating Revenue
Elroilab 24-Jan-2024 Machinery (B2B) Generating Revenue
Changupin 15-Nov-2023 Early Stage VC Business/Productivity Software Generating Revenue
Featuring 20-Sep-2023 Early Stage VC Business/Productivity Software Generating Revenue
You’re viewing 10 of 148 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Magna Investment (Seoul) Exits (37)

Company Name Exit Date Exit Type Exit Size
Microalgae Ask Us 24-Sep-2024 Merger/Acquisition
Kickgoing 26-Aug-2024
Wehuddling 30-Jun-2024
Jan153 Biotech 17-Jun-2024
D&D Pharmatech 02-May-2024
Fleximind 02-Apr-2024
YBiologics 05-Dec-2023
Macaron M 26-Nov-2023
TSP Biochem 20-Oct-2023 Out of Business
EnhancedBio 27-Sep-2023 Merger/Acquisition
You’re viewing 10 of 37 exits. Get the full list »

Magna Investment (Seoul) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Magna Investment (Seoul) Management, Team & Partners (11)

Name Title Deals Funds Boards Office
Keele Park Chief Executive Officer Seoul, South Korea
Ki-il Park Chief Executive Officer Seoul, South Korea
Yang-Woo Jeon President & Head of Venture Investment Division Seoul, South Korea
Chang-gi Park Director Seoul, South Korea
Hyun Tae Kim Executive Director Seoul, South Korea
You’re viewing 5 of 11 team members. Get the full list »

Magna Investment (Seoul) FAQs

  • What is Magna Investment (Seoul)?

    Founded in 2010, Magna Investment is a venture capital firm based in Seoul, South Korea.

  • When was Magna Investment (Seoul) founded?

    Magna Investment (Seoul) was founded in 2010.

  • Who is the CEO of Magna Investment (Seoul)?

    Keele Park and Ki-il Park are the CEOs of Magna Investment (Seoul).

  • Where is Magna Investment (Seoul) headquartered?

    Magna Investment (Seoul) is headquartered in Seoul, South Korea.

  • What is Magna Investment (Seoul)'s total asset value?

    Magna Investment (Seoul) has around in total assets under management.

  • How many investments has Magna Investment (Seoul) made?

    Magna Investment (Seoul) has made 148 investments.

  • What has Magna Investment (Seoul) invested in?

    Magna Investment (Seoul) has made numerous investments in companies like Ensol Biosciences, Altos Biologics, and CastingN within the Biotechnology and Media and Information Services (B2B) industries.

  • What has Magna Investment (Seoul) invested in recently?

    Magna Investment (Seoul)'s latest investment was on 12-Aug-2024 in Ensol Biosciences, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »